OJMI  Vol.4 No.4 , December 2014
The Impact of Obesity on the Left Ventricular Ejection Fraction Using Echocardiography
ABSTRACT
Global left ventricle chamber function in obese patients is assessed, most commonly, by means of the ejection fraction. The preferred noninvasive modality for evaluating regional wall motion and overall ventricular performance is usually color-flow Doppler transthoracic echocardiography. The aim of this study was to evaluate the relationship of left ventricular ejection fraction to body mass index (BMI) measure of obesity in obese patients by using echocardiography. A prospective cohort study was conducted in the period of July 2012 to September 2014 in the ultrasound department of the Sudan Heart Center in Khartoum-Sudan, among a group of 250 obese participants of acute myocardial infarction (AMI) (67.2% males and 32.8% females) and their ages range from 22 to 86 years; mean age of 41 ± 1.2 years. Echocardiography studies were performed using MyLab 50 XVision-Esaote echocardiography machine equipped with 2.5 MHz phased array probe. Standard Statistical Package for the Social Sciences (SPSS) was used to analyze the results. The mean BMI was 28.6 ± 5.4 kg/m2. Significant relationship is found between left ventricle ejection fraction and BMI (P < 0.001). BMI is a useful statistical tool to track the body size trends in a multicentric population in Sudan. Left ventricular ejection fraction allows ventricular function to be assessed without the need for further body size adjustment.

Cite this paper
Elkhader, B. , Abdulla, A. , Omer, M. , Fagiri, M. and Mahmoud, M. (2014) The Impact of Obesity on the Left Ventricular Ejection Fraction Using Echocardiography. Open Journal of Medical Imaging, 4, 172-177. doi: 10.4236/ojmi.2014.44024.
References
[1]   Antmen, E.M. and boaunwald, E. (2008) Acute MI. Harrison’s Principle of Internal Medicine. 17th Edition, McGraw-Hill Professional, New York.

[2]   Haslam, D.W. and James, W.T. (2005) Obesity. Lancet, 366, 1197-1209.
http://dx.doi.org/10.1016/S0140-6736(05)67483-1

[3]   Frühbeck, G., Diez-Caballero, A., Gómez-Ambrosi, J., Cienfuegos, J.A. and Salvador, J. (2003) Preventing Obesity. Doctors Underestimate Obesity. BMJ, 326, 102-103.
http://dx.doi.org/10.1136/bmj.326.7380.102

[4]   Frühbeck, G. (2004) Screening and Interventions for Obesity in Adults. Annals of Internal Medicine, 141, 245-246.
http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00026

[5]   Yusuf, S., Hawken, S., Ounpuu, S., Bautista, L., Franzosi, M.G., Commerford, P., Lang, C.C., Rumboldt, Z., Onen, C.L., Lisheng, L., Tanomsup, S., Wangai Jr., P., Razak, F., Sharma, A.M. and Anand, S.S. (2005) Obesity and the Risk of Myocardial Infarction in 27,000 Participants from 52 Countries: A Case-Control Study. Lancet, 366, 1640-1649.
http://dx.doi.org/10.1016/S0140-6736(05)67663-5

[6]   Calle, E.E., Thun, M.J., Petrelli, J.M., Rodriguez, C. and Heath, C.W. (1999) Body-Massindex and Mortality in a Prospective Cohort of U.S. Adults. The New England Journal of Medicine, 341, 1097-1105.
http://dx.doi.org/10.1056/NEJM199910073411501

[7]   Mehta, L., Devlin, W., McCullough, P.A., O’Neill, W.W., Skelding, K.A., Stone, G.W., Boura, J.A. and Grines, C.L. (2007) Impact of Body Mass Index on Outcomes after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction. The American Journal of Cardiology, 99, 906-910.
http://dx.doi.org/10.1016/j.amjcard.2006.11.038

[8]   Steinberg, B.A., Cannon, C.P., Hernandez, A.F., Pan, W., Peterson, E.D. and Fonarow, G.C. (2007) Medical Therapies and Invasive Treatments for Coronary Artery Diseaseby Body Mass: The “Obesity Paradox” in the Get with the Guidelines Database. The American Journal of Cardiology, 100, 1331-1335.
http://dx.doi.org/10.1016/j.amjcard.2007.06.019

[9]   Rea, T.D., Heckbert, S.R., Kaplan, R.C., Psaty, B.M., Smith, N.L., Lemaitre, R.N. and Lin, D. (2001) Body Mass Index and the Risk of Recurrent Coronary Events Following Acute Myocardial Infarction. The American Journal of Cardiology, 88, 467-472.
http://dx.doi.org/10.1016/S0002-9149(01)01720-9

[10]   Stevens, J., Cai, J., Pamuk, E.R., Williamson, D.F., Thun, M.J. and Wood, J.L. (1998) The Effect of Age on the Association between Body-Mass Index and Mortality. The New England Journal of Medicine, 338, 1-7.
http://dx.doi.org/10.1056/NEJM199801013380101

[11]   Yusuf, S., Reddy, S., Ounpuu, S. and Anand, S. (2001) Global Burden of Cardiovascular Diseases: Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization. Circulation, 104, 2746-2753.
http://dx.doi.org/10.1161/hc4601.099487

[12]   Antman, E., Bassand, J.P., Klein, W., Ohman, M., Sendon, J.L., Rydén, L., Simoons, M. and Tendera, M. (2000) Myo-cardial Infarction Redefined—A Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Journal of the American College of Cardiology, 36, 959-969.
http://dx.doi.org/10.1016/S0735-1097(00)00804-4

[13]   Thygesen, K., Alpert, J.S. and White, H.D. (2007) Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal Definition of Myocardial Infarction. European Heart Journal, 28, 2525-2538.
http://dx.doi.org/10.1093/eurheartj/ehm355

[14]   Pfeffer, M.A., Braunwald, E., Moye, L.A., Basta, L., Brown Jr., E.J., Cuddy, T.E., Davis, B.R., Geltman, E.M., Goldman, S., Flaker, G.C., Klein, M., Lamas, G.A., Packer, M., Roulean, J., Roulean, J.L., Rutherford, J., Wertheimer, J.H. and Hawkins, C.M. (1992) Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction—Results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. The New England Journal of Medicine, 327, 669-677.
http://dx.doi.org/10.1056/NEJM199209033271001

[15]   Volpi, A., De Vita, C., Franzosi, M.G., Geraci, E., Maggioni, A.P., Mauri, F., Negri, E., Santoro, E., Tavazzi, L. and Tongnoni, G. (1993) Determinants of 6-Month Mortality in Survivors of Myocardial Infarction after Thrombolysis. Results of the GISSI-2 Database. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-2 Data Base. Circulation, 88, 416-429.
http://dx.doi.org/10.1161/01.CIR.88.2.416

[16]   Senior, R., Sridhara, B.S., Basu, S., Henley, M., Handler, C.E., Raftery, E.B. and Lahiri, A. (1994) Comparison of Radionuclide Ventriculography and 2D Echocardiography for the Measurement of Left Ventricular Ejection Fraction Following Acute Myocardial Infarction. European Heart Journal, 15, 1235-1239.

[17]   Ioannidis, J.P., Trikalinos, T.A. and Danias, P.G. (2002) Electrocardiogram-Gated Single-Photon Emission Computed Tomography versus Cardiac Magnetic Resonance Imaging for the Assessment of Left Ventricular Volumes and Ejection Fraction: A Meta-Analysis. Journal of the American College of Cardiology, 39, 2059-2068.
http://dx.doi.org/10.1016/S0735-1097(02)01882-X

[18]   McGowan, J.H. and Cleland, J.G. (2003) Reliability of Reporting Left Ventricular Systolic Function by Echocardiography: A Systematic Review of 3 Methods. American Heart Journal, 146, 388-397.
http://dx.doi.org/10.1016/S0002-8703(03)00248-5

[19]   Benjelloun, H., Cranney, G.B., Kirk, K.A., Blackwell, G.G., Lotan, C.S. and Pohost, G.M. (1991) Interstudy Reproducibility of Biplane Cine Nuclear Magnetic Resonance Measurements of Left Ventricular Function. American Journal of Cardiology, 67, 1413-1420.
http://dx.doi.org/10.1016/0002-9149(91)90473-X

[20]   Hyun, I.Y., Kwan, J., Park, K.S. and Lee, W.H. (2001) Reproducibility of Tl-201 and Tc-99 m Sestamibi Gated Myocardial Perfusion SPECT Measurement of Myocardial Function. Journal of Nuclear Cardiology, 8, 182-187.
http://dx.doi.org/10.1067/mnc.2001.112753

[21]   Kober, L., Torp-Pedersen, C., Carlsen, J., Videbaek, R. and Egeblad, H. (1994) An Echocardiographic Method for Selecting High Risk Patients Shortly after Acute Myocardial Infarction, for Inclusion in Multi-Centre Studies (as Used in the TRACE Study). Trandolapril Cardiac Evaluation. European Heart Journal, 15, 1616-1620.

[22]   Powell, B.D., Redfield, M.M., Bybee, K.A., Freeman, W.K. and Rihal, C.S. (2006) Association of Obesity with Left Ventricular Remodeling and Diastolic Dysfunction in Patients without Coronary Artery Disease. American Journal of Cardiology, 98, 116-120.
http://dx.doi.org/10.1016/j.amjcard.2006.01.063

[23]   Fox, E., Taylor, H., Andrew, M., Han, H., Mohamed, E., Garrison, R. and Skelton, T. (2004) Body Mass Index and Blood Pressure Influences on Left Ventricular Mass and Geometry in African Americans: The Atherosclerotic Risk in Communities (ARIC) Study. Hypertension, 44, 55-60.
http://dx.doi.org/10.1161/01.HYP.0000132373.26489.58

[24]   Iacobellis, G., Ribaudo, M.C., Leto, G., Zappaterreno, A., Vecci, E., Di Mario, U. and Leonetti, F. (2002) Influence of Excess Fat on Cardiac Morphology and Function: Study in Uncomplicated Obesity. Obesity Research, 10, 767-773.
http://dx.doi.org/10.1038/oby.2002.104

[25]   Iacobellis, G. and Sharma, A.M. (2007) Obesity and the Heart: Redefinition of the Relationship. Obesity Reviews, 8, 35-39.
http://dx.doi.org/10.1111/j.1467-789X.2006.00257.x

[26]   Levy, D., Anderson, K.M., Savage, D.D., Kannel, W.B., Christiansen, J.C. and Castelli, W.P. (1988) Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors. The Framingham Heart Study. Annals of Internal Medicine, 108, 7-13.
http://dx.doi.org/10.7326/0003-4819-108-1-7

[27]   Turkbey, E.B., McClelland, R.L., Kronmal, R.A., Burke, G.L., Bild, D.E., Tracy, R.P., Arai, A.E., Lima, J.A. and Bluemke, D.A. (2010) The Impact of Obesity on the Left Ventricle: The Multi-Ethnic Study of Atherosclerosis (MESA). JACC: Cardiovascular Imaging, 3, 266-274.
http://dx.doi.org/10.1016/j.jcmg.2009.10.012

 
 
Top